Pacific Biosciences of California Total Current Liabilities

As of the most recent data (March 2026), PACB shows a total current liabilities of $33M. That compares with $67M in the prior-year period — down 49.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PACB's total current liabilities is now $33M (was $67M) — a 49.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pacific Biosciences of California is outperforming or lagging.

Tracking PACB's total current liabilities over time shows whether Pacific Biosciences of California is scaling, shrinking, or reshaping that part of the business. The current reading is $33M That compares with $67M in the prior-year period — down 49.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Pacific Biosciences of California's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $33M) with ownership activity and broader fundamentals.

Pacific Biosciences of California's total current liabilities is $33M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.